Buy Antabuse

Antabuse

Antabuse (Disulfiram): Generic Medication Overview

Disulfiram, sold under the brand name Antabuse, is a prescription medication classified in the Addiction & Quit Smoking therapeutic category. It is supplied as a pill in strengths of 250 mg and 500 mg. In Hong Kong, disulfiram is regulated by the Pharmacy and Poisons Board (PPB) of the Department of Health and is available only with a doctor's prescription.

How Disulfiram Works in the Body

Disulfiram inhibits the enzyme acetaldehyde dehydrogenase (ALDH), which is responsible for converting acetaldehyde-an intermediate metabolite of ethanol-into acetate. When a person taking disulfiram consumes alcohol, acetaldehyde accumulates, producing unpleasant physiological reactions such as flushing, nausea, vomiting, headache, and palpitations. This reaction, known as the disulfiram-ethanol reaction, serves as a strong deterrent to drinking.

• Onset of effect: The enzyme inhibition is irreversible and persists for up to 2 weeks after the last dose.
• Duration: Steady-state inhibition is achieved after several days of daily dosing.
• Metabolism: Disulfiram is metabolized primarily in the liver through oxidation and conjugation pathways, with a half-life of 60-120 hours for its active metabolites.

Conditions Treated with Disulfiram

Disulfiram is approved by the PPB for the treatment of alcohol dependence in adults who have achieved initial abstinence and are motivated to maintain sobriety. It is used as part of a comprehensive program that includes counseling, behavioral therapy, and support groups.

• Primary indication: Adults who have stopped drinking and need a pharmacologic deterrent against relapse.
• Typical patient profile: Individuals who are motivated, have no severe liver disease, and can adhere to a daily medication schedule.

Evidence-Based Off-Label Uses

Research has explored disulfiram for cocaine dependence and for managing alcohol-related cravings in certain psychiatric populations. These applications are not approved by the PPB and should only be considered under close medical supervision, with a clear discussion of the limited evidence and potential risks.

Disclaimer: Off-label use requires medical supervision and individualized risk assessment.

Who Should Use Disulfiram? Contraindications

Absolute contraindications

• Known hypersensitivity to disulfiram or any of its excipients.
• Acute alcohol intoxication or consumption of alcoholic beverages.
• Severe liver disease (e.g., cirrhosis, hepatitis with elevated transaminases).
• Severe cardiac disease (e.g., unstable angina, recent myocardial infarction).
• Pregnancy (disulfiram is classified as Category X) and breastfeeding.

Relative contraindications

• Moderate hepatic impairment (monitor liver function tests closely).
• Renal impairment (dose adjustment rarely required, but monitor renal function).
• Use of medications that can cause severe reactions when combined with disulfiram (e.g., metronidazole, certain cough syrups containing alcohol).

Special populations

• Pregnancy & lactation: Disulfiram is contraindicated; it can cause fetal harm and is excreted in breast milk.
• Elderly: Start with the lowest effective dose (250 mg) and monitor for confusion, falls, and hepatic function.
• Patients with psychiatric disorders: May experience increased irritability or psychosis; careful monitoring is advised.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Drowsiness or fatigue (commonly reported).
• Headache.
• Metallic or garlic-like taste in the mouth.
• Skin rash or mild itching.
• Mild peripheral neuropathy (tingling or numbness in extremities).

Serious Adverse Events

• Hepatotoxicity: Elevated liver enzymes, hepatitis, or liver failure; requires immediate medical evaluation.
• Severe disulfiram-ethanol reaction: Profuse vomiting, hypotension, cardiovascular collapse, respiratory distress.
• Psychotic reactions: Hallucinations or severe mood changes, especially in patients with a history of mental illness.
• Peripheral neuropathy: May become disabling if untreated.

Drug Interactions

• Alcohol-containing products: Any ingestion (including sauces, tinctures, certain mouthwashes) can trigger a severe reaction.
• Metronidazole and certain antitubercular agents (e.g., isoniazid): Can potentiate the disulfiram-ethanol reaction.
• CYP2E1 substrates (e.g., chlorzoxazone, some anesthetics): Disulfiram inhibits CYP2E1, potentially increasing plasma levels of these drugs.
• Anticoagulants (e.g., warfarin): May increase anticoagulant effect; monitor INR closely.
• Sulfonylureas (e.g., chlorpropamide): May cause enhanced hypoglycemia.

General advice: Patients should furnish a complete medication list-including over-the-counter drugs, supplements, and herbal products-to their healthcare provider before starting disulfiram.

Food and Lifestyle Interactions

• Avoid all alcoholic beverages, including those used in cooking, desserts, and certain dental products.
• Alcohol-containing foods (e.g., sauces, marinades) can also provoke reactions.
• No known restriction on caffeine or nicotine, but abrupt cessation of smoking may increase anxiety; discuss supportive measures with a clinician.
• Operating heavy machinery is generally safe, but patients experiencing dizziness or severe fatigue should exercise caution.

Dosing and Administration Guidelines

• Standard dosing:

• Initial phase: 250 mg taken once daily for 1-2 weeks, after confirming complete abstinence from alcohol.

• Maintenance phase: 250 mg daily may be continued indefinitely; some clinicians prescribe 500 mg once daily in selected cases, but the 250 mg dose is the most common and has a well-established safety profile.

• Special populations:

• Renal or hepatic impairment: Begin with 250 mg daily; monitor liver enzymes (ALT, AST) every 2-4 weeks for the first 3 months.

• Elderly: Start at 250 mg and assess tolerance before considering any increase.

• Administration:

• Swallow the pill whole with water; do not crush or chew.

• Take the dose at the same time each day, preferably in the morning.

• Can be taken with or without food.

• Missed dose:

• If a dose is missed and alcohol has not been consumed, take it as soon as remembered unless it is close to the next scheduled dose-do not double-dose.

• Overdose:

• Symptoms may include severe nausea, vomiting, respiratory depression, and cardiac arrhythmias. Seek emergency medical care; treatment is supportive, and gastric decontamination may be considered if presentation is early.

• Discontinuation:

• No tapering is required because disulfiram does not cause physiological dependence. However, patients should be counseled that the protective deterrent effect will diminish within 2 weeks after stopping the medication.

Monitoring and Follow-Up

• Baseline labs: Liver function tests (ALT, AST, bilirubin) before initiation.

• Routine monitoring: Repeat liver enzymes every 2-4 weeks for the first three months, then at regular intervals (e.g., every 6 months) or as clinically indicated.

• Clinical assessment:

• Evaluate adherence and any occurrence of accidental alcohol exposure.

• Assess for new or worsening neurological symptoms (e.g., numbness, tingling).

• Review concomitant medications for potential interactions.

• When to contact a healthcare provider:

• Development of severe nausea, vomiting, abdominal pain, jaundice, or dark urine.

• Appearance of skin rash, itching, or neuropathic symptoms.

• Any unintentional alcohol consumption.

Storage and Handling

• Store at room temperature (15 °C-30 °C), protected from moisture and direct sunlight.
• Keep the bottle tightly closed and out of reach of children and pets.
• Do not use the medication after the expiration date printed on the label.
• Dispose of unused tablets according to local pharmacy-take-back programs or the disposal instructions on the package.

Medication-Specific Glossary

Disulfiram-Ethanol Reaction

A severe, predictable response (flushing, nausea, vomiting, tachycardia, hypotension) that occurs when alcohol is consumed while disulfiram is active in the body.

CYP2E1

A liver enzyme involved in metabolizing ethanol and several other drugs; disulfiram inhibits this enzyme, leading to altered concentrations of CYP2E1 substrates.

Hepatotoxicity

Liver injury caused by a drug, manifested by elevated liver enzymes or clinical signs such as jaundice; a recognized risk with disulfiram especially in patients with pre-existing liver disease.

Peripheral Neuropathy

Damage to peripheral nerves, presenting as tingling, numbness, or weakness, which can be a rare adverse effect of long-term disulfiram use.

Therapeutic Window

The dosage range in which a drug produces its desired effect without causing unacceptable side effects; for disulfiram, the standard therapeutic window is generally 250 mg-500 mg daily.

Alcohol Abstinence Monitoring

The practice of measuring biomarkers (e.g., ethyl glucuronide) or using patient self-reports to verify that a patient has not consumed alcohol before initiating disulfiram therapy.

Medical Disclaimer

This article provides educational information about Antabuse (disulfiram) and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.